Synonyms: | |
Status: | Approved |
Entry Type: | Small molecule |
Molecule Category: | UNKNOWN |
ATC: | N05AG01 |
UNII: | C5QA4GLR9M |
InChI Key | QOYHHIBFXOOADH-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C29H31F2N3O |
Molecular Weight | 475.58 |
AlogP | 5.31 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 1.0 |
Number of Rotational Bond | 7.0 |
Polar Surface Area | 35.58 |
Molecular species | BASE |
Aromatic Rings | 3.0 |
Heavy Atoms | 35.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Ion channel
Ligand-gated ion channel
Glycine receptor
|
1200 | - | - | - | - | |
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 2300 | - | - | - | |
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Short peptide receptor (family A GPCR)
Opioid receptor
|
- | - | - | 500 | - | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Dopamine receptor
|
- | - | - | - | 96 | |
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Monoamine receptor
Serotonin receptor
|
- | - | - | 1188 | - |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Schizophrenia | 3 | D012559 | ClinicalTrials |
Anxiety | 3 | D001007 | ClinicalTrials |
Dementia | 3 | D003704 | ClinicalTrials |
Depressive Disorder | 3 | D003866 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 1841-19-6 |
ChEBI | 93369 |
ChEMBL | CHEMBL46516 |
DrugBank | DB04842 |
DrugCentral | 1222 |
EPA CompTox | DTXSID7045152 |
FDA SRS | C5QA4GLR9M |
Human Metabolome Database | HMDB0015590 |
Guide to Pharmacology | 85 |
PharmGKB | PA162565878 |
PubChem | 3396 |
SureChEMBL | SCHEMBL42082 |
ZINC | ZINC000000537755 |